NL-OMON52496
Recruiting
Not Applicable
A combination of pre-screening for DPD deficiency by genotyping/phenotyping methods and pharmacokinetics-guided dosing of 5-FU for precision treatment to prevent severe toxicity in gastrointestinal cancer patients. - DPD guided 5FU precision treatment in GI cancer
Isala Klinieken0 sites75 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Isala Klinieken
- Enrollment
- 75
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •age 18 years and older
- •histological proof of gastro\-intestinal cancer
- •patient is considered for treatment with capecitabine or 5\-FU
- •acceptable safety laboratory values
- •ECOG performance status 0\-2
- •able and willing to give written informed consent
- •able and willing to undergo blood sampling for DPYD genotyping, DPD
- •phenotyping and pharmacokinetic analysis
Exclusion Criteria
- •symptomatic or uncontrolled central nervous system metastases
- •patient who cannot submit itself to the formal follow\-up for psychological,
- •social, family or geographical reasons
- •women who are pregnant or breast\-feeding
- •women not consenting to use adequate contraceptive precautions during the
- •significant serious pathology or any instable medical condition (cardiac
- •pathology uncontrolled, myocardial infarction within 6 months before enrolment,
- •systemic active uncontrolled infection, cirrhosis (Child\-Pugh score C), renal
- •failure (GFR \< 20 ml/min))
- •any investigational agent within 4 weeks before enrolment
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
A combination of pre-screening for DPD deficiency by genotyping/phenotyping methods and pharmacokinetics-guided dosing of 5-FU for precision treatment to prevent severe toxicity in gastrointestinal cancer patientsNL-OMON29105Isala65
Recruiting
Not Applicable
Potential Patient Screening for Late-Onset Pompe Disease in Suspected Sleep Apneaate-Onset Pompe DiseaseJPRN-UMIN000039191ara Medical University1,500
Not yet recruiting
Not Applicable
Helping children thrive: Enhancing early detection of developmental delays in doctors offices.CTRI/2024/05/066735Kollisetti Divya Sree
Not yet recruiting
Not Applicable
screening for High blood screening, high blood sugar, and certain important risk factors for heart diseases among patient bystandaresCTRI/2024/01/061485Kasturba Medical College Manipal
Recruiting
Not Applicable
Assessment of Radiotherapy in the management of Dupuytren’s DiseaseACTRN12618000951257Genesis Care568